Share Twitter LinkedIn Facebook Email Primo N. Lara, Jr., MD, explains the convenience factor of oral TKIs influences decisions related to advanced renal cell carcinoma (RCC) treatment Advertisement
Alcohol Consumption and Cancer Risk: Insights from the 2025 Surgeon Generalโs Advisory Breast Cancer 3 Mins Read
Genitourinary Cancer [2025] Treatment Breakthroughs: ASCO GU 2025 Highlights Nataliya Mar, MD – MOASC Genitourinary 6 Mins Read
